English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Calithera Biosciences
Carol Ostrow
| Dec 26, 2017
Calithera presents results of breast cancer treatment study
Ruth de Jauregui
| Jun 17, 2017
Bristol-Myers Squibb, Calithera Biosciences to evaluate Opdivo, CB-839 in treating non-small cell lung cancer
Robert Hadley
| Jun 16, 2017
Calithera says trials indicate new drug can inhibit growth of solid tumors
Trending
+
Regulatory
C.D. Marsden
| Apr 12, 2025
Empower Pharmacy: Eli Lilly lawsuit is ‘Big Pharma’s attempt to limit patient and provider choice’
+
Pharmaceuticals
Patient Daily
| Apr 10, 2025
Researchers uncover mechanisms behind metabolic demands in nursing mothers
+
Pharmaceuticals
Patient Daily
| Apr 15, 2025
UCSF neurosurgeon: '340B is a drug discount program that hospitals exploit as an additional revenue stream'
+
Pharmaceuticals
Patient Daily
| Apr 15, 2025
Former Domestic Policy Council director: 340B program turns large non-profit hospitals into 'pure profit' centers
